Literature DB >> 1610220

Intraaortic balloon counterpulsation: patterns of usage and outcome in cardiac surgery patients.

L L Creswell1, M Rosenbloom, J L Cox, T B Ferguson, N T Kouchoukos, T L Spray, M K Pasque, T B Ferguson, T H Wareing, C B Huddleston.   

Abstract

Between January 1, 1986, and May 6, 1991, 7,884 cardiac surgical procedures requiring cardiopulmonary bypass were performed at our institution, including 672 (9.8% of adult procedures) performed in 669 patients that were associated with preoperative (n = 240), intraoperative (n = 353), or postoperative (n = 79) use of an intraaortic balloon pump. The mean age of recipients was 65.3 years (range, 16 to 89 years). Intraaortic balloon pump usage increased during the study period from 6.4% of patients (83/1,298) in 1986 to 12.7% of patients (169/1,333) in 1990. The relative distribution between preoperative (mean, 35.7%), intraoperative (52.5%), and postoperative (11.8%) insertion remained nearly constant during the study period. The overall operative (30-day) mortality for patients with preoperative, intraoperative, or postoperative insertion of the intraaortic balloon pump was 19.6%, 32.3%, and 40.5%, respectively (X2 = 16.4; p less than 0.001). Although use of the intraaortic balloon pump in the intraoperative and postoperative settings is accompanied by a favorable outcome in most patients, the high associated mortality suggests the need for earlier use of the intraaortic balloon pump or other supportive measures such as the ventricular assist device.

Entities:  

Mesh:

Year:  1992        PMID: 1610220     DOI: 10.1016/0003-4975(92)91133-t

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  7 in total

1.  The magnitude of the T cell response to a clinically significant dose of influenza virus is regulated by TRAIL.

Authors:  Erik L Brincks; Prajwal Gurung; Ryan A Langlois; Emily A Hemann; Kevin L Legge; Thomas S Griffith
Journal:  J Immunol       Date:  2011-09-21       Impact factor: 5.422

2.  Risk modeling for ventricular assist device support in post-cardiotomy shock.

Authors:  Bahaaldin Alsoufi; Vivek Rao; Augustine Tang; Manjula Maganti; Robert Cusimano
Journal:  J Saudi Heart Assoc       Date:  2012-02-13

3.  The need for intra aortic balloon pump support following open heart surgery: risk analysis and outcome.

Authors:  Haralabos Parissis; Michael Leotsinidis; Mohammad Tauqeer Akbar; Efstratios Apostolakis; Dimitrios Dougenis
Journal:  J Cardiothorac Surg       Date:  2010-04-05       Impact factor: 1.637

4.  A clinical score to predict the need for intraaortic balloon pump in patients undergoing coronary artery bypass grafting.

Authors:  Antonio Miceli; Simon M J Duggan; Radek Capoun; Francesco Romeo; Massimo Caputo; Gianni D Angelini
Journal:  Ann Thorac Surg       Date:  2010-08       Impact factor: 4.330

5.  Temporal trends in the use of intraaortic balloon pump associated with percutaneous coronary intervention in the United States, 1998-2008.

Authors:  Hiren Patel; Anupama Shivaraju; Gregg C Fonarow; Hui Xie; Weihua Gao; Adhir R Shroff; Mladen I Vidovich
Journal:  Am Heart J       Date:  2014-06-06       Impact factor: 4.749

6.  Combined association of liver and renal injury by intra-aortic balloon pump malposition.

Authors:  Feridoun Sabzi; Aghigheh Heidari; Reza Faraji
Journal:  ARYA Atheroscler       Date:  2018-05

7.  Intra-aortic balloon pump experience: a single center study comparing with and without sheath insertion.

Authors:  Yücel Özen; Mehmet Aksut; Davut Cekmecelioglu; Mehmet Dedemoglu; Ozge Altas; Sabit Sarikaya; Murat Bulent Rabus; Kaan Kirali
Journal:  J Cardiovasc Thorac Res       Date:  2018-09-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.